Shirkhoda A, Baird S
Department of Diagnostic Radiology, M.D. Anderson Cancer Center, Houston, TX 77030.
Abdom Imaging. 1994 Jan-Feb;19(1):39-42. doi: 10.1007/BF02165859.
Thirty patients with metastatic breast carcinoma to the liver underwent systemic chemotherapy. Twenty-four of these patients also received hepatic arterial infusion chemotherapy, three in conjunction with hepatic artery embolization. The morphologic changes of the liver believed to be due to chemotoxic effect of treatment occurred in 27 patients, and were evaluated by serial computed tomography (CT) examinations. These included fatty changes in seven patients, severe cirrhotic changes in four, localized atrophy with regional contour changes in three, and areas of low density in the regions of previously treated metastases in 13. The CT features of cirrhosis included density changes along with nodular irregularity of the hepatic borders with marked decrease in liver size and development of ascites.
30例发生肝转移的乳腺癌患者接受了全身化疗。其中24例患者还接受了肝动脉灌注化疗,3例同时联合肝动脉栓塞术。27例患者出现了被认为是治疗化学毒性作用所致的肝脏形态学改变,并通过系列计算机断层扫描(CT)检查进行评估。这些改变包括7例患者出现脂肪变性,4例出现严重肝硬化改变,3例出现局部萎缩伴区域轮廓改变,13例在先前治疗的转移灶区域出现低密度区。肝硬化的CT特征包括密度改变以及肝边缘结节状不规则,肝脏大小明显缩小并出现腹水。